Cameroon vs Ghana: Population requiring preventive chemotherapy for schistosomiasis
Cameroon
6.80 million
in 2024
Ghana
8.31 million
in 2024
Cameroon rank
12th
Ghana rank
9th
Population requiring preventive chemotherapy for schistosomiasis over time
- Cameroon
- Ghana
How they compare
Ghana currently reports 8.31 million against 6.80 million in Cameroon, a difference of 1.51 million.
That makes Ghana's figure about 1.2 times Cameroon's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Cameroon ahead.
Cameroon ranks 12th and Ghana ranks 9th of 52 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.46 million | 8.62 million | 2.16 million | Ghana |
| 2020s | 6.02 million | 10.10 million | 4.09 million | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Cameroon or Ghana?
- Ghana, at 8.31 million against 6.80 million in Cameroon as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Cameroon and Ghana?
- 1.51 million, with Ghana ahead.
- How many years of comparable data are there for Cameroon and Ghana?
- 15 years are reported by both, from 2010 to 2024.
- How do Cameroon and Ghana rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Cameroon ranks 12th and Ghana ranks 9th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.